West Michigan Advisors »

Cidara Therapeutics shares owned by West Michigan Advisors

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by West Michigan Advisors from 13F filings

Historical chart of West Michigan Advisors investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by West Michigan Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by West Michigan Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 17k 95.76
2025-06-30 $804k 17k 48.71
2025-03-31 $291k 14k 21.54

More positions owned by West Michigan Advisors

Gentex Corp Common Stock (GNTX)
Amplify CWP Enhanced DIV Inm ETF Etf (DIVO)
Microsoft Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Innovator US Eqy Power Buffer ETF Etf (PSEP)
Broadcom Common Stock (AVGO)
Vanguard S&P 500 ETF Etf (VOO)
JPMorgan Chase Common Stock (JPM)
Huntington Banc Common Stock (HBAN)
J P Morgan Nasdaq EQT PRM Inc ETF IV Etf (JEPQ)
Capital Group Global GRWT Eqy ETF Etf (CGGO)
Amazon.Com Common Stock (AMZN)
Newmont Corp Common Stock (NEM)
Apple Common Stock

View all positions for West Michigan Advisors

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Point72 Asset Management
BVF
Vivo Capital
Vanguard Group
BlackRock
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
Morgan Stanley
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics